The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...
It's often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We asked ...
Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback